论文部分内容阅读
目的:研究丁苯酞软胶囊对脑血管疾病的临床治疗效果,并对其安全性进行分析。方法:采用对照研究的方式选择门诊及住院部收治的85例脑血管疾病患者为研究对象,根据治疗方式的不同将其分为治疗组(40例)和对照组(45例),对照组患者行常规西医治疗,治疗组患者在对照组基础上联合丁苯酞软胶囊治疗,对比分析两组患者的临床疗效及安全性。结果:两组患者均未见明显不良反应;治疗前神经功能受损评分元显著差异;治疗后组间治疗总有效率比较X2=8.2611,治疗后神经功能受损评分明显降低,组间比较t=5.3688;P<0.05表示差异具有统计学意义。结论:丁苯酞软胶囊对脑血管疾病的治疗效果确切,促进患者病情恢复,安全性高,具有较高的临床使用价值。
Objective: To study the clinical effect of butylphthalide soft capsule on cerebrovascular disease and to analyze its safety. METHODS: A total of 85 patients with cerebrovascular disease who were treated in outpatient department and inpatient department were selected as the control study. The patients were divided into treatment group (40 cases) and control group (45 cases) according to different treatment methods. Patients in the control group Routine Western medicine treatment, the treatment group patients in the control group based on butylphthalide soft capsule treatment, comparative analysis of two groups of patients with clinical efficacy and safety. Results: There were no significant adverse reactions in both groups. The scores of neurological impairment before treatment were significantly different. After treatment, the total effective rate of treatment was X2 = 8.2611. The score of neurological impairment was significantly decreased after treatment, = 5.3688; P <0.05 means the difference is statistically significant. CONCLUSION: Butylphthalide soft capsule has definite curative effect on cerebrovascular disease, which can promote the recovery of patients’ condition, high safety and high clinical value.